Relation of ABO blood groups to coronary lesion complexity in patients with stable coronary artery disease

TANBOĞA, İbrahim Halil; IŞIK, Turgay; Aksakal, Enbiya; günaydın, zeki yüksel; KAYA, Ahmet; Kaya, Yasemin; Kurt, Mustafa

Relation of ABO blood groups to coronary lesion complexity in patients with stable coronary artery disease

Ahmet KAYA, (Ordu Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Ordu, Türkiye)

İbrahim Halil TANBOĞA, (Atatürk Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Erzurum, Türkiye)

Mustafa KURT, (Erzurum Eğitim ve Araştırma Hastanesi, Kardiyoloji Kliniği, Erzurum, Türkiye)

Turgay IŞIK, (Erzurum Eğitim ve Araştırma Hastanesi, Kardiyoloji Kliniği, Erzurum, Türkiye)

Yasemin KAYA, (Erzurum Bölge Eğitim ve Araştırma Hastanesi, İç Hastalıkları Bölümü, Erzurum, Türkiye)

Zeki Yüksel GÜNAYDIN, (Ordu Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Ordu, Türkiye)

Enbiya AKSAKAL (Atatürk Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Erzurum, Türkiye)

Anadolu Kardiyoloji Dergisi

0 1

Yıl: 2014 Cilt: 14 Sayı: 1 Sayfa Aralığı: 55 - 60 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Relation of ABO blood groups to coronary lesion complexity in patients with stable coronary artery disease

Öz:

Objective: We aimed to investigate the relationship between ABO blood groups and complexity of coronary lesions assessed by SYNTAX score (SS) in stable coronary artery disease (CAD) patients. Methods: Our cross-sectional and observational study population consisted of 559 stable CAD patients. From all patients, ABO blood group was determined and the SS was calculated as low SYNTAX score (0-22), intermediate SYNTAX (23-32) score and high SYNTAX score (>32). Statistical analysis was performed using Student’s t-test or Mann-Whitney U test, ANOVA, or Kruskal-Wallis test and chi-square test. Multiple logistic regression analysis was used to identify the independent predictors of high SS. Results: The analysis between the SS tertiles revealed that the frequency of non-O blood group was significantly higher in the upper SS tertiles (56.2% vs. 75.9 vs. 80.2%, p<0.05). However, the frequencies of Rh types were similar in all tertiles. Multiple logistic regression analysis was applied for determining the predictors of high SS. Accordingly, non-O blood group (OR: 2.68, 95% CI 1.65-4.35, p<0.001), LV-EF (OR: 0.93, 95% CI 0.91-0.95, p<0.001), LDL(OR: 0.98, 95% CI 0.97-0.99, p<0.001), and e-GFR (OR: 0.99, 95% CI 0.98-0.98, p<0.001) were found to be the independent predictors of high SS. Conclusion: We showed that there were significant associations between ABO blood groups and complexity of angiographic CAD.

Anahtar Kelime:

Konular: Kalp ve Kalp Damar Sistemi

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Libby P Ridker PM, Hansson GK; Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009; 54: 2129-38. [CrossRef]
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-95. [CrossRef]
3. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001; 285: 2481-5. [CrossRef]
4. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994; 330: 1041-6. [CrossRef]
5. Mallika V, Goswami B, Rajappa M. Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective. Angiology 2007; 58: 513-22. [CrossRef]
6. Sarı İ, Özer O, Davutoğlu V, Görgülü S, Eren M, Aksoy M. ABO blood group distribution and major cardiovascular risk factors in patients with acute myocardial infarction. Blood Coagul Fibrinolysis 2008; 19: 231-4. [CrossRef]
7. Franchini M, Capra F, Targher G, Montagnana M, Lippi G. Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thromb J 2007; 5: 14. [CrossRef]
8. O'Donnell J, Boulton FE, Manning RA, Laffan MA. Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels. Arterioscler Thromb Vasc Biol 2002; 22: 335-41. [CrossRef]
9. Biancari F, Satta J, Pokela R, Juvonen T. ABO blood group distribution and severity of coronary artery disease among patients undergoing coronary artery bypass surgery in Northern Finland. Thromb Res 2002; 108: 195-6. [CrossRef]
10. Sianos G, Morel MA, Kappetein AP Morice MC, Colombo A, Dawkins K, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005; 1: 219-27.
11. Tanboğa IH, Ekinci M, Işık T, Kurt M, Kaya A, Sevimli S. Reproducibility of SYNTAX score: from core lab to real world. J Interv Cardiol 2011; 24: 302-6. [CrossRef]
12. Aksakal E, Tanboğa IH, Kurt M, Kaya A, Topçu S, Kalkan K, et al. Predictors of coronary lesions complexity in patients with stable coronary artery disease. Angiology 2013; 64: 304-9. [CrossRef]
13. Serruys PW, Morice MC, Kappetein AP Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-72. [CrossRef]
14. Aksakal E, Tanboğa IH, Kurt M, Kaygın MA, Kaya A, Işık T, et al. The relation of serum gamma-glutamyl transferase levels with coronary lesion complexity and long-term outcome in patients with stable coronary artery disease. Atherosclerosis 2012; 221: 596-601. [CrossRef]
15. SYNTAX working-group. SYNTAX score calculator: Available at URL: www.syntaxscore.com. Accessed date at September 2012.
16. Schmitz G, Kaminski WE. ABCA2: a candidate regulator of neural transmembrane lipid transport. Cell Mol Life Sci 2002; 59:1285-95. [CrossRef]
17. Carpeggiani C, Coceani M, Landi P Michelassi C, L'Abbate A. ABO blood group alleles: A risk factor for coronary artery disease. An angiographic study. Atherosclerosis 2010; 211: 461-6. [CrossRef]
18. Wu O, Bayoumi N, Vickers MA, Clark P ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008; 6: 62-9. [CrossRef]
19. Ruggeri ZM, Zimmerman TS. von Willebrand factor and von Willebrand disease. Blood 1987; 70: 895-904.
20. Vischer UM. von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost 2006; 4: 1186-93. [CrossRef]
21. Mannucci PM. von Willebrand factor: a marker of endothelial damage? Arterioscler Thromb Vasc Biol 1998; 18: 1359-62. [CrossRef]
22. Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998; 67: 395-424. [CrossRef]
23. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997; 96: 1102-8. [CrossRef]
24. Ruggeri ZM, Dent JA, Saldivar E. Contribution of distinct adhesive interactions to platelet aggregation in flowing blood. Blood 1999; 94: 172-8.
25. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
26. Preston AE, Barr A. The Plasma Concentration of Factor Viii in the Normal Population. II. The Effects of Age, Sex and Blood Group. Br J Haematol 1964; 10: 238-45. [CrossRef]
27. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003; 170: 191-203. [CrossRef]
28. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998; 351: 88-92. [CrossRef]
29. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM Jr, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 1997; 96: 4219-25. [CrossRef]
30. Barbalic M, Dupuis J, Dehghan A, Bis JC, Hoogeveen RC, Schnabel RB, et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet 2010; 19: 1863-72. [CrossRef]
31. Pare G, Chasman DI, Kellogg M, Zee RY, Rifai N, Badola S, et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet 2008; 4: e1000118. [CrossRef]
32. Kiechl S, Pare G, Barbalic M, Qi L, Dupuis J, Dehghan A, et al. Association of variation at the ABO locus with circulating levels of soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin: a meta-analysis. Circ Cardiovasc Genet 2011; 4: 681-6. [CrossRef]
33. Nydegger UE, Wuillemin WA, Julmy F, Meyer BJ, Carrel TP Association of ABO histo-blood group B allele with myocardial infarction. Eur J Immunogenet 2003; 30: 201-6. [CrossRef]
34. Garrison RJ, Havlik RJ, Harris RB, Feinleib M, Kannel WB, Padgett SJ. ABO blood group and cardiovacular disease: the Framingham study. Atherosclerosis 1976; 25: 311-8. [CrossRef]
35. Lee HF, Lin YC, Lin CP Wang CL, Chang CJ, Hsu LA. Association of blood group A with coronary artery disease in young adults in Taiwan. Intern Med 2012; 51: 1815-20. [CrossRef]
36. He M, Wolpin B, Rexrode K, Manson JE, Rimm E, Hu FB, et al. ABO blood group and risk of coronary heart disease in two prospective cohort studies. Arterioscler Thromb Vasc Biol 2012; 32: 2314-20. [CrossRef]
37. Amirzadegan A, Salarifar M, Sadeghian S, Davoodi G, Darabian C, Goodarzynejad H. Correlation between ABO blood groups, major risk factors, and coronary artery disease. Int J Cardiol 2006; 110: 256-8. [CrossRef]
38. Eastlund T. The histo-blood group ABO system and tissue transplantation. Transfusion 1998; 38: 975-88. [CrossRef]
39. Reilly MP Li M, He J, Ferguson JF, Stylianou IM, Mehta NN, et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 2011; 377: 383-92. [CrossRef]

APA	KAYA A, TANBOĞA İ, Kurt M, IŞIK T, Kaya Y, günaydın z, Aksakal E (2014). Relation of ABO blood groups to coronary lesion complexity in patients with stable coronary artery disease. , 55 - 60.
Chicago	KAYA Ahmet,TANBOĞA İbrahim Halil,Kurt Mustafa,IŞIK Turgay,Kaya Yasemin,günaydın zeki yüksel,Aksakal Enbiya Relation of ABO blood groups to coronary lesion complexity in patients with stable coronary artery disease. (2014): 55 - 60.
MLA	KAYA Ahmet,TANBOĞA İbrahim Halil,Kurt Mustafa,IŞIK Turgay,Kaya Yasemin,günaydın zeki yüksel,Aksakal Enbiya Relation of ABO blood groups to coronary lesion complexity in patients with stable coronary artery disease. , 2014, ss.55 - 60.
AMA	KAYA A,TANBOĞA İ,Kurt M,IŞIK T,Kaya Y,günaydın z,Aksakal E Relation of ABO blood groups to coronary lesion complexity in patients with stable coronary artery disease. . 2014; 55 - 60.
Vancouver	KAYA A,TANBOĞA İ,Kurt M,IŞIK T,Kaya Y,günaydın z,Aksakal E Relation of ABO blood groups to coronary lesion complexity in patients with stable coronary artery disease. . 2014; 55 - 60.
IEEE	KAYA A,TANBOĞA İ,Kurt M,IŞIK T,Kaya Y,günaydın z,Aksakal E "Relation of ABO blood groups to coronary lesion complexity in patients with stable coronary artery disease." , ss.55 - 60, 2014.
ISNAD	KAYA, Ahmet vd. "Relation of ABO blood groups to coronary lesion complexity in patients with stable coronary artery disease". (2014), 55-60.

APA	KAYA A, TANBOĞA İ, Kurt M, IŞIK T, Kaya Y, günaydın z, Aksakal E (2014). Relation of ABO blood groups to coronary lesion complexity in patients with stable coronary artery disease. Anadolu Kardiyoloji Dergisi, 14(1), 55 - 60.
Chicago	KAYA Ahmet,TANBOĞA İbrahim Halil,Kurt Mustafa,IŞIK Turgay,Kaya Yasemin,günaydın zeki yüksel,Aksakal Enbiya Relation of ABO blood groups to coronary lesion complexity in patients with stable coronary artery disease. Anadolu Kardiyoloji Dergisi 14, no.1 (2014): 55 - 60.
MLA	KAYA Ahmet,TANBOĞA İbrahim Halil,Kurt Mustafa,IŞIK Turgay,Kaya Yasemin,günaydın zeki yüksel,Aksakal Enbiya Relation of ABO blood groups to coronary lesion complexity in patients with stable coronary artery disease. Anadolu Kardiyoloji Dergisi, vol.14, no.1, 2014, ss.55 - 60.
AMA	KAYA A,TANBOĞA İ,Kurt M,IŞIK T,Kaya Y,günaydın z,Aksakal E Relation of ABO blood groups to coronary lesion complexity in patients with stable coronary artery disease. Anadolu Kardiyoloji Dergisi. 2014; 14(1): 55 - 60.
Vancouver	KAYA A,TANBOĞA İ,Kurt M,IŞIK T,Kaya Y,günaydın z,Aksakal E Relation of ABO blood groups to coronary lesion complexity in patients with stable coronary artery disease. Anadolu Kardiyoloji Dergisi. 2014; 14(1): 55 - 60.
IEEE	KAYA A,TANBOĞA İ,Kurt M,IŞIK T,Kaya Y,günaydın z,Aksakal E "Relation of ABO blood groups to coronary lesion complexity in patients with stable coronary artery disease." Anadolu Kardiyoloji Dergisi, 14, ss.55 - 60, 2014.
ISNAD	KAYA, Ahmet vd. "Relation of ABO blood groups to coronary lesion complexity in patients with stable coronary artery disease". Anadolu Kardiyoloji Dergisi 14/1 (2014), 55-60.